196 related articles for article (PubMed ID: 24788917)
1. Disrupted bone remodeling leads to cochlear overgrowth and hearing loss in a mouse model of fibrous dysplasia.
Akil O; Hall-Glenn F; Chang J; Li A; Chang W; Lustig LR; Alliston T; Hsiao EC
PLoS One; 2014; 9(5):e94989. PubMed ID: 24788917
[TBL] [Abstract][Full Text] [Related]
2. Association of Hearing Loss and Otologic Outcomes With Fibrous Dysplasia.
Boyce AM; Brewer C; DeKlotz TR; Zalewski CK; King KA; Collins MT; Kim HJ
JAMA Otolaryngol Head Neck Surg; 2018 Feb; 144(2):102-107. PubMed ID: 29192304
[TBL] [Abstract][Full Text] [Related]
3. Parallel mechanisms suppress cochlear bone remodeling to protect hearing.
Jáuregui EJ; Akil O; Acevedo C; Hall-Glenn F; Tsai BS; Bale HA; Liebenberg E; Humphrey MB; Ritchie RO; Lustig LR; Alliston T
Bone; 2016 Aug; 89():7-15. PubMed ID: 27085457
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-13 is required for osteocytic perilacunar remodeling and maintains bone fracture resistance.
Tang SY; Herber RP; Ho SP; Alliston T
J Bone Miner Res; 2012 Sep; 27(9):1936-50. PubMed ID: 22549931
[TBL] [Abstract][Full Text] [Related]
5. Hypothyroidism and the ear: electrophysiological, morphological, and chemical considerations.
Meyerhoff WL
Laryngoscope; 1979 Oct; 89(10 Pt 2 Suppl 19):1-25. PubMed ID: 491810
[TBL] [Abstract][Full Text] [Related]
6. [Fibrous dysplasia of the temporal bone].
Makowski A; Makowska-Piontek A; Barańska D
Otolaryngol Pol; 2005; 59(4):611-5. PubMed ID: 16273872
[TBL] [Abstract][Full Text] [Related]
7. Hearing loss in Paget's disease: a temporal bone histopathology study.
Dimitriadis PA; Bamiou DE; Bibas AG
Otol Neurotol; 2012 Feb; 33(2):142-6. PubMed ID: 22222574
[TBL] [Abstract][Full Text] [Related]
8. Osteoprotegrin knockout mice demonstrate abnormal remodeling of the otic capsule and progressive hearing loss.
Zehnder AF; Kristiansen AG; Adams JC; Kujawa SG; Merchant SN; McKenna MJ
Laryngoscope; 2006 Feb; 116(2):201-6. PubMed ID: 16467704
[TBL] [Abstract][Full Text] [Related]
9. Wnt pathway inhibition with the porcupine inhibitor LGK974 decreases trabecular bone but not fibrosis in a murine model with fibrotic bone.
Lung H; Wentworth KL; Moody T; Zamarioli A; Ram A; Ganesh G; Kang M; Ho S; Hsiao EC
JBMR Plus; 2024 May; 8(5):ziae011. PubMed ID: 38577521
[TBL] [Abstract][Full Text] [Related]
10. Gs G protein-coupled receptor signaling in osteoblasts elicits age-dependent effects on bone formation.
Hsiao EC; Boudignon BM; Halloran BP; Nissenson RA; Conklin BR
J Bone Miner Res; 2010 Mar; 25(3):584-93. PubMed ID: 20200944
[TBL] [Abstract][Full Text] [Related]
11. Ligand-mediated activation of an engineered gs g protein-coupled receptor in osteoblasts increases trabecular bone formation.
Hsiao EC; Millard SM; Louie A; Huang Y; Conklin BR; Nissenson RA
Mol Endocrinol; 2010 Mar; 24(3):621-31. PubMed ID: 20150184
[TBL] [Abstract][Full Text] [Related]
12. Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength.
Kamiya N; Shuxian L; Yamaguchi R; Phipps M; Aruwajoye O; Adapala NS; Yuan H; Kim HK; Feng JQ
Bone; 2016 Oct; 91():53-63. PubMed ID: 27402532
[TBL] [Abstract][Full Text] [Related]
13. Conditional deletion of E11/Podoplanin in bone protects against ovariectomy-induced increases in osteoclast formation and activity.
Staines KA; Hopkinson M; Dillon S; Stephen LA; Fleming R; Sophocleous A; Buttle DJ; Pitsillides AA; Farquharson C
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894854
[TBL] [Abstract][Full Text] [Related]
14. Fibrous dysplasia of the temporal bone: ten new cases demonstrating the spectrum of otologic sequelae.
Megerian CA; Sofferman RA; McKenna MJ; Eavey RD; Nadol JB
Am J Otol; 1995 Jul; 16(4):408-19. PubMed ID: 8588639
[TBL] [Abstract][Full Text] [Related]
15. Prolactin expression in the cochlea of aged BALB/c mice is gender biased and correlates to loss of bone mineral density and hearing loss.
Marano RJ; Tickner J; Redmond SL
PLoS One; 2013; 8(5):e63952. PubMed ID: 23667691
[TBL] [Abstract][Full Text] [Related]
16. Densitometry of the cochlear capsule and correlation between bone density loss and bone conduction hearing loss in otosclerosis.
Huizing EH; de Groot JA
Acta Otolaryngol; 1987; 103(5-6):464-8. PubMed ID: 3618174
[TBL] [Abstract][Full Text] [Related]
17. [Bone dysplasias of the face. Apropos of 2 cases, one of them in a hard of hearing patient with ossicular malformation].
Claux J; Coll J; Ané P; Chamayou P; Goguet R
J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1981 Oct; 30(8):489-91. PubMed ID: 6457892
[No Abstract] [Full Text] [Related]
18. Dysfunction of the cochlea contributing to hearing loss in acoustic neuromas: an underappreciated entity.
Roosli C; Linthicum FH; Cureoglu S; Merchant SN
Otol Neurotol; 2012 Apr; 33(3):473-80. PubMed ID: 22377650
[TBL] [Abstract][Full Text] [Related]
19. Activated Gs signaling in osteoblastic cells alters the hematopoietic stem cell niche in mice.
Schepers K; Hsiao EC; Garg T; Scott MJ; Passegué E
Blood; 2012 Oct; 120(17):3425-35. PubMed ID: 22859604
[TBL] [Abstract][Full Text] [Related]
20. On the biology of the bony otic capsule and the pathogenesis of otosclerosis.
Bloch SL
Dan Med J; 2012 Oct; 59(10):B4524. PubMed ID: 23158898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
